Aug 7, 2026
The solid phase synthesis reactor from Bioland Instrument is a fully integrated platform designed to meet the needs of modern pharmaceutical production and research. The system works with borosilicate glass, PLC-driven automation, and a high-performance PTFE filtration module. It can handle peptide synthesis, solid-phase organic reactions, and complex API intermediates all in one GMP-compliant tank. Pharmaceutical developers can accurately control a very large temperature range, see what's going on at all times, and use designs that can be easily scaled up or down from bench scale to pilot scale. This solid phase synthesis reactor is not just a piece of glassware; it is a complete solution for speeding up drug development while meeting the strictest regulatory and quality standards. It is certified to CE and ISO standards and can be custom engineered for explosion-proof and automated configurations.
Solid phase synthesis is an important method in the creation of new medicines because it lets scientists build complicated molecules in steps that are very pure and can be repeated. Iterative coupling, washing, and deprotection processes can happen in a solid phase synthesis reactor while the growing chain stays attached to a solid base. This makes cleaning up between steps a lot easier, cuts down on mistakes made by hand, and allows automation. A lot of the most important treatment improvements made today are based on solid phase synthesis. This includes oligonucleotide and small-molecule libraries as well as peptide APIs like semaglutide and tirzepatide.
In traditional solid phase processes, there are a lot of different tanks, hand moves, and filtering steps that add variation and the risk of pollution. Bioland Instrument combines reaction, washing, and filtration into a single borosilicate glass vessel that has a PTFE filter built in. Full synthetic cycles are run without introducing intermediates to outside containers. This cuts down on cross-contamination and shortens the cycle time by up to 30 percent. The design of this solid phase synthesis reactor is in line with GMP documentation standards because all the important steps happen in a single unit operation that can be tracked.
One of the fastest-growing areas of pharmaceuticals is peptide drug research, and the solid phase synthesis reactor is perfect for this job. The clear glass body lets you see the resin swelling, coupling progress, and colorimetric reaction indicators like ninhydrin tests in real time. With its exact temperature control from -20°C to 200°C and customizable overhead stirrer, the reactor gives you the repeatability you need for sequences longer than 30 amino acids. Clients have confirmed binding rates above 99 percent per cycle, which is necessary for putting together medicinal peptides that meet the purity standards set by regulatory agencies.
One common problem in drug development is making a pilot process that can be used again and again after a successful lab synthesis. The solid phase synthesis reactor platform comes in three sizes: 20L, 50L, and 100L. All three sizes have the same basic geometry. Because of this design consistency, scientists can make batches of peptides that are bigger than grams without having to test each parameter again. Bioland Instrument also makes special 30L vessels for customers who need vessels with a middle size. The engineering team works closely with customers to make sure that the resin loads, mixing profiles, and filtration processes are all optimized for each individual molecule.
For reliable binding results in solid phase synthesis, it is important that the resin beads are mixed evenly. The solid phase synthesis reactor has an overhead stirrer with a speed that can be changed so that it can tumble resins gently or mix them more vigorously for reactions where diffusion is limited. The stir speed can change automatically between the coupling, washing, and deprotection stages thanks to programmable profiles. This makes sure that the best mass transfer happens during every cycle. This level of automation gets rid of the need for operator-dependent inconsistency and allows for 24/7 running without being watched when liquid dose units are added.
Temperature changes the speed of a reaction, the stability of a material, and the formation of byproducts. The solid phase synthesis reactor has a glass tank with a jacket and a high-low temperature agitator that works well from -80°C to 200°C and keeps the temperature stable. Cryogenic conditions help slow down coupling processes that are sensitive to racemization, while high temperatures speed up steps of deprotection and make condensations more difficult. PT100 sensors built in give real-time feedback to the PLC, which keeps track of every change in temperature for batch tracking and regulatory review.
Solvents that can catch fire, like DMF, DCM, or diethyl ether, are used in a lot of solid phase processes. Bioland Instrument has versions of the solid phase synthesis reactor that are completely safe from explosions. These versions have ATEX-rated motors, nitrogen purge lines, and seals that get rid of static electricity. These systems also have electric lifting frames and built-in safety interlocks that keep operators safe while cleaning and filtering. Pharmaceutical companies that are running large-scale peptide campaigns have switched to these explosion-proof setups so they can safely grow beyond the limits of normal lab glassware.
Pharmaceutical industry can't do without automation anymore, and the solid phase synthesis reactor does it right out of the box. The PLC-based control system has an easy-to-use touchscreen interface for managing recipes, setting the order of steps, and keeping track of parameters. Synthesis routines can be made by operators with conditional logic, warning limits, and automatic wash processes. When the reactor is connected to a building's distributed control system, it turns into a part of a larger GMP manufacturing network that can help with ongoing peptide production projects.
Because it doesn't react with many common chemical solvents, weak acids, and bases, borosilicate glass is the best material for making medicines. The solid phase synthesis reactor stays chemically neutral even after thousands of rounds of synthesis. This makes sure that metal ions never get into the API and affect its quality. When compared to stainless steel options, this glass-based platform offers the highest level of purity guarantee for clients making metal-sensitive APIs like certain antibiotic scaffolds or radiopharmaceutical precursors.
During solid phase synthesis, it is very helpful to be able to see the reaction going on or not going so well because color changes, resin discoloration, and precipitation are often signs of reaction progress or problems. The solid phase synthesis reactor lets operators see the whole working volume, so they can be sure that the material has completely broken down, find any filter fouling, and check the clarity of the washing endpoint. This visual intelligence goes along with instrumental data and speeds up the fixing process during process development.
The integrated PTFE filtration module is central to the solid phase synthesis reactor’s performance. Standard configurations include PTFE sintered filters, but optional stainless steel, titanium, and fabric filter media accommodate different pressure and chemical requirements. Quick-release clamps allow filter replacement in under ten minutes, supporting rapid turnover between projects. For multi-product facilities, this flexibility is essential for maintaining campaign timelines without costly downtime.
A defining advantage of the solid phase synthesis reactor is its ability to execute long synthetic sequences entirely within a single vessel. By alternating coupling, washing, deprotection, and final cleavage steps inside one reactor, the system eliminates transfer losses and intermediate exposure to contamination. This approach has been validated in the production of thymopentin, antimicrobial peptides, and peptide carrier materials, where cumulative yield improvements of 12 to 18 percent have been observed compared with traditional multi-vessel workflows.
A Swiss pharmaceutical company developing a novel antimicrobial peptide faced yield losses above 20 percent during scale-up from 5L to 50L working volumes. The client’s pain points included poor resin mixing, slow filtration, and excessive solvent consumption. Bioland Instrument supplied a 50L solid phase synthesis reactor with explosion-proof design, programmable PLC control, and a quick-change PTFE filter. After three validation batches, the client reported the following outcomes: coupling efficiency improved from 94 percent to 99.2 percent, total cycle time decreased by 22 percent, and overall yield rose to 87 percent. The client described the equipment as a transformational investment that shortened their development timeline by nearly four months.
A South Korean manufacturer of cosmetic-grade peptides needed to scale production while maintaining batch-to-batch consistency. Their existing manual synthesis setup could not deliver reliable purity for export markets. The customer’s pain points included operator-dependent variability, cross-contamination between peptides, and high rejection rates. Bioland Instrument delivered a customized 30L solid phase synthesis reactor with automated reagent dosing and CIP-ready cleaning. Within two months of installation, the client achieved peptide purity above 98.5 percent across 25 consecutive batches, and rejection rates dropped from 8 percent to under 1 percent. The factory has since ordered a second 50L unit for capacity expansion.
An Indian contract research organization supporting multiple global pharmaceutical clients needed flexible synthesis capacity for diverse peptide projects. Their challenges included rapid changeover between molecules, limited floor space, and strict regulatory expectations from international sponsors. Bioland Instrument configured a 100L solid phase synthesis reactor with modular filtration, an electric lifting frame, and a PLC interface compatible with their existing electronic batch record system. The CRO now runs up to four different peptide sequences per week without cross-contamination, satisfying sponsor audits and improving project margins by approximately 15 percent.
Bioland Instrument supports every solid phase synthesis reactor installation with comprehensive engineering services. The R&D team assists with resin selection guidance, solvent compatibility reviews, and process optimization consultations. Each customer is assigned a dedicated project specialist who tracks manufacturing progress with weekly photo and video updates, performs pre-shipment inspection together with the client, and provides lifetime technical support. This partnership approach has made Bioland Instrument a preferred supplier for pharmaceutical manufacturers, research institutes, and contract developers across Europe, Asia, and the Americas.
The solid phase synthesis reactor from Bioland Instrument represents a comprehensive answer to the evolving demands of pharmaceutical development. By uniting borosilicate glass transparency, modular filtration, programmable automation, and GMP-aligned documentation, the system empowers researchers and manufacturers to execute complex syntheses with unmatched control. Real-world deployments across peptide API developers, cosmetic peptide producers, and global CROs confirm measurable gains in yield, purity, and cycle efficiency. Backed by 15 years of engineering expertise and a customer-first service model, Bioland Instrument delivers the confidence pharmaceutical innovators need.
Standard models cover 20L, 30L, 50L, and 100L working volumes, with custom engineering available for larger or specialized geometries.
Yes, the solid phase synthesis reactor is widely used for peptide, antimicrobial peptide, and thymopentin synthesis, supporting coupling efficiencies above 99 percent per cycle.
Fully explosion-proof versions with ATEX-rated components, nitrogen purge, and electric lifting frames are available for flammable solvent systems.
PTFE sintered filters ship standard, with optional stainless steel, titanium, and various fabric or membrane media for different chemical and pressure requirements.
Yes, every order includes a dedicated project specialist, lifetime technical support, a one-year warranty, and on-site commissioning assistance with FAT options.
Bioland Instrument is more than a manufacturer; we are your strategic partner in pharmaceutical process innovation. Our solid phase synthesis reactor is helping peptide developers, API manufacturers, and research organizations worldwide achieve higher yields, faster cycles, and flawless regulatory compliance. From custom explosion-proof engineering to PLC automation and lifelong technical service, every detail is built around your success. Join the pharmaceutical leaders who have already accelerated timelines and reduced costs with Bioland Instrument. Reach out today at info@biolandequip.com and let us engineer the next breakthrough in your drug development journey.
1. Fields, G. B. Solid-Phase Peptide Synthesis. Academic Press, 1997.
2. Atherton, E., and Sheppard, R. C. Solid Phase Peptide Synthesis: A Practical Approach. IRL Press, 1989.
3. International Council for Harmonisation. ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients. ICH Harmonised Guideline, 2000.
4. U.S. Food and Drug Administration. 21 CFR Part 210 and 211: Current Good Manufacturing Practice for Pharmaceuticals. FDA, 2023.
5. Chan, W. C., and White, P. D. Fmoc Solid Phase Peptide Synthesis: A Practical Approach. Oxford University Press, 2000.
6. Gooding, O. W. “Process Chemistry in the Pharmaceutical Industry: Challenges and Opportunities.” Organic Process Research & Development, Vol. 22, No. 3, 2018, pp. 256–272.
2024-05-16
Pharmaceutical Company
The reactor is beautifully mirror-polished and fully complies with GMP requirements for the pharmaceutical industry. The performance is excellent! Overall, we are very satisfied! We also provided with some feedback on our process improvements, which we hope will be helpful.
2024-04-09
Laboratory
Excellent and professional service. Always reply our questions very fast. All reactors and chiller we received are good too.
2024-02-15
Research Institute
Quality is beyond our expectation actually. After we got the extraction equipment and started using it, the performance was beyond our expectation. Very easy to use and very efficient to run. Service always respond us very quickly. Was also very helpful to help us. Thanks Bioland team. Very happy to work with you.
2023-11-20
Biotech Company
We are happy about the new purchase as always. Equipment and services are both good.
2023-08-05
Instrument Lab
This is the second order with Bioland instrument and everything is good as the first dateText.
2023-05-12
Global Trading Partner
Bioland instrument team is very helpful and professional. The sales helped us select the right equipment for our application, and their logistics people handled the transportation and customs declaration for our shipment. All that saved us a lot of work.
